JPMorgan analyst Robbie Marcus raised the firm’s price target on Stryker to $315 from $285 and keeps an Overweight rating on the shares. The company reported a very strong start to the year with double-digit organic growth and guidance moving up, the analyst tells investors in a research note.
Published first on TheFly
See today’s best-performing stocks on TipRanks >>
Read More on SYK: